Research in rats indicated that M.pruriens exhibited twice the anti-Parkinsonian activity compared
to synthetic L-DOPA, suggesting that M. pruriens may contain unidentified anti-Parkinsonian compounds that enhance the efficacy of L-DOPA (Hussian and Manyam, 1997).